XML 81 R44.htm IDEA: XBRL DOCUMENT v3.25.4

Share-Based Compensation (Tables)

12 Months Ended

Dec. 31, 2025

Share-Based Payment Arrangement [Abstract]

Schedule of Weighted Average Option Fair Values and Assumptions

The assumptions used in determining the fair value of the stock options granted during December 31, 2025, 2024 and 2023 were as follows:

			Years Ended December 31,
			2025						2024						2023
Weighted average fair value of grants			$46.74						$63.61						$59.77
Dividend yield			1.41%						1.09%						1.09%
Volatility			23.06%						26.66%						27.14%
Risk-free interest rate			4.28%						4.31%						4.15%
Expected life (in years)			4.70						4.60						4.50

Schedule of Stock Option Activity

A summary of the Company’s stock option activity as of December 31, 2025, and changes during the year ended December 31, 2025, are presented in the following table:

			Shares						Weighted Average Exercise Price						Weighted-Average Remaining Contractual Term (years)						Aggregate Intrinsic Value
Stock Options
Outstanding at January 1, 2025			998,856						$	191.96					6.63						$	24.9
Granted			82,470						196.07
Exercised			(28,408)						128.86
Forfeited			(98,717)						212.92
Outstanding at December 31, 2025			954,201						$	192.03					5.82						$	8.9
Vested and expected to vest at December 31, 2025			942,815						$	191.69					5.79						$	8.9
Exercisable at December 31, 2025			671,427						$	181.50					4.95						$	8.9

Schedule of Restricted Stock Activity

A summary of the Company’s restricted stock activity as of December 31, 2025, and changes during the year ended December 31, 2025, are presented in the following table:

Restricted Stock			Shares						Weighted-Average Grant Date Fair Value
Unvested at January 1, 2025			175,991						$	201.27
Granted			106,875						191.13
Vested			(64,072)						190.37
Forfeited			(27,972)						205.42
Unvested at December 31, 2025			190,822						$	198.64

Schedule of Unvested Cash-settled Restricted Stock Activity

A summary of the Company’s unvested cash-settled restricted stock activity as of December 31, 2025, and changes during the year ended December 31, 2025, are presented in the following table:

Cash-Settled Restricted Stock			Shares						Weighted-Average Fair Value
Unvested at January 1, 2025			55,395						$	209.29
Granted			32,090						195.10
Vested			(19,131)						186.52
Forfeited			(6,062)						177.94
Unvested at December 31, 2025			62,292						$	177.94

Schedule of Weighted Average Performance Share Units Fair Values and Assumptions

The assumptions used in the Monte Carlo simulation model to determine the fair value of the market condition portion of the performance share units granted during December 31, 2025, 2024 and 2023 were as follows:

			Years Ended December 31,
			2025						2024						2023
Weighted average fair value of grants			$232.44						$349.59						$308.18
Dividend yield			—%						—%						—%
Volatility			22.93%						22.23%						27.00%
Risk-free interest rate			4.23%						4.45%						4.37%
Expected life (in years)			2.94						2.94						2.94

Schedule of Performance Shares Units Activity

A summary of the Company’s performance share unit activity as of December 31, 2025, and changes during the year ended December 31, 2025, are presented in the following table:

Performance Share Units			Shares						Weighted-Average Grant Date Fair Value
Unvested at January 1, 2025			72,825						$	299.87
Granted			43,360						216.98
Vested			(15,530)						234.23
Forfeited			(22,450)						264.20
Unvested at December 31, 2025			78,205						$	267.78

Schedule of Pre-Tax Compensation Cost

Total compensation cost related to all share-based awards was as follows:

			Years Ended December 31,
			2025						2024						2023
Stock options expense			$	6.1					$	9.8					$	9.9
Restricted stock expense			15.2						8.3						5.7
Cash-settled restricted stock expense			3.2						3.4						3.4
Performance share units expense			6.0						7.7						6.0
Total pre-tax share-based compensation expense(1)			30.5						29.2						25.0
Income tax benefit			(4.1)						(3.2)						(2.7)
Total share-based compensation expense, net of income taxes			$	26.4					$	26.0					$	22.3

(1) Pre-tax compensation cost is recognized in the Company’s Consolidated Statements of Income depending on the functional area of the underlying employees, as follows:

			Years Ended December 31,
			2025						2024						2023
Cost of sales			$	1.9					$	1.6					$	1.4
Selling, general and administrative expenses			29.2						27.6						23.6
Restructuring expenses and asset impairments(2)			(0.6)						—						—
Total pre-tax share-based compensation expense			$	30.5					$	29.2					$	25.0

(2) During the year ended December 31, 2025, a benefit of $0.6 million was recognized in Restructuring expenses and asset impairments in the Company’s Consolidated Statements of Income related to forfeitures of share-based compensation awards resulting from previously announced restructuring actions initiated during the first quarter of 2025.

X

- Definition

Schedule of Share-based Compensation, Unvested Cash-settled Restricted Stock Activity [Table Text Block]

+ References

No definition available.

+ Details

Name:	iex_ScheduleofSharebasedCompensationUnvestedCashsettledRestrictedStockActivityTableTextBlock
Namespace Prefix:	iex_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Schedule of Share-based Payment Award, Equity Instruments Other than Options, Valuation Assumptions [Table Text Block]

+ References

No definition available.

+ Details

Name:	iex_ScheduleofSharebasedPaymentAwardEquityInstrumentsOtherthanOptionsValuationAssumptionsTableTextBlock
Namespace Prefix:	iex_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (h)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Subparagraph (f)(2)
-Name Accounting Standards Codification
-Paragraph 2
-Section 50
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the number and weighted-average grant date fair value for outstanding performance shares.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Subparagraph (c)
-Paragraph 2
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ShareBasedCompensationPerformanceSharesAwardOutstandingActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration